申请人:Groneberg D. Robert
公开号:US20050256316A1
公开(公告)日:2005-11-17
Disclosed are compounds of the Formula (I) and pharmaceutically acceptable salts and prodrugs thereof, wherein A, B, R
1
, R
2
, R
3
, and R
4
are as defined in the specification. Such compounds are tyrosine phosphatase inhibitors and useful in the treatment or prevention of Type II Diabetes Mellitus. Also encompassed by the invention are formulations comprising the noted compounds, processes for preparing such compounds, a method for treating or preventing Type II Diabetes Mellitus.
本发明涉及公式(I)的化合物及其药学上可接受的盐和前药,其中A、B、R1、R2、R3和R4如规范中所定义。这些化合物是酪氨酸磷酸酶抑制剂,可用于治疗或预防2型糖尿病。本发明还包括含有上述化合物的配方、制备这些化合物的方法以及治疗或预防2型糖尿病的方法。